尊龙Z6官方网站

logo1
Investor Relations
Announcements & Notices Financial Reports Listing Documents Investor Calendar Investor Presentation Corporate Governance Stock Information IR Contact

Science

Partnership
Building strong and lasting partnership is essential to the success of our business and our customers.  We pursue innovation through both internal R&D and external collaboration.  Partnerships and collaborations are critical to evolving our portfolio and driving our long-term sustainability.

● Out-licensing: we seek partners with global R&D and commercial expertise to help realize the full potential of our innovative assets on a global or regional level.
● In-licensing: we are constantly seeking and evaluating both late-stage clinical assets that may complement our in-house pipelines and first-in-class compounds with breakthrough potential.
● Strategic collaboration: we are open to working with any entities, industrial or academic institutions on any scale. Also, we welcome diversified novel ideas with the potential to help our patients and maximize the power of our portfolio.
首页| 尊龙Z6(中国集团)官方网站

In July 2019, we entered into an exclusive license agreement with X4 Pharmaceuticals, Inc. (“X4”) and obtained the rights for the development, manufacturing and commercialization of the licensed compound ABSK081 (mavorixafor), which was formerly known as X4P-001, collectively with any product containing such licensed compound (the “X4 Product”) in the licensed territory of mainland China, Taiwan, Hong Kong and Macau.

首页| 尊龙Z6(中国集团)官方网站
首页| 尊龙Z6(中国集团)官方网站

In October 2019, we entered into a combination therapy development agreement with Shanghai Junshi Biomedical Technology Co., Ltd. to develop a combination therapy for the treatment of triple-negative breast cancer (TNBC).

首页| 尊龙Z6(中国集团)官方网站
首页| 尊龙Z6(中国集团)官方网站

In November 2019, we entered into an exclusive license agreement with AstraZeneca and obtained the global rights for the development, manufacturing and commercialization of ABSK091 (AZD4547).

首页| 尊龙Z6(中国集团)官方网站
For more information on collaboration
with Abbisko please contact our business development team at
首页| 尊龙Z6(中国集团)官方网站

Tel:(+86) 021-68912098

E-Mail:Bd@abbisko.com
    PR@abbisko.com
    IR@abbisko.com

Copyright © 2021 All rights reserved:Abbisko Therapeautics     沪ICP备17056565号-1    gatb 沪公网安备31011502401700    PRIVACY POLICY

【网站地图】